The previously described mechanism of NEP downregulation in HF, therefore, may be, just like other compensatory mechanisms in HF [e.g., myocardial hypertrophy (28) and renin-angiotensin-aldosterone system (RAAS) activation (29)], considered to be at least partly maladaptive. The gene discussed is MME; the disease is cardiac hypertrophy.